Literature DB >> 35278136

Quality of life of patients with hematological malignancies and factors affecting health state utility values.

Keiichi Osaki1, Shinichiro Morishita2, Suzuho Takami1, Yuki Sakai1, Akiho Kamimura1, Atsushi Shindo1, Eri Kawata3.   

Abstract

PURPOSE: It is well studied that physical function and social background affect the quality of life (QoL) of cancer patients. However, differences in QoL by age and factors affecting health state utility values (HSUV) of patients with hematological malignancies have not yet been sufficiently investigated. Our aim is to investigate the factors that affect QoL and HSUV in such patients.
METHODS: A total of 32 patients with hematological malignancies on outpatient chemotherapy were included. QoL and HSUV were evaluated using the EuroQol-5 Dimension 5-level (EQ-5D-5L). Physical function was assessed using grip strength, knee extension strength, 6-min walking distance, and Short Physical Performance Battery (SPPB). Fatigue was assessed using Brief Fatigue Inventory (BFI), and nutritional status was assessed using Mini Nutritional Assessment-Short Form (MNA-SF).
RESULTS: In the EQ-5D-5L, a high percentage of the patients were aware of mobility problems and pain/discomfort, and mobility problems were more common in the older-aged group (≥ 65 years old, n = 16) than in the middle-aged group (< 65 years old, n = 16). In addition, the older-aged group showed lower HSUV and physical function. SPPB (β = 0.38, p < 0.01), BFI (β =  - 0.58, p < 0.01), and MNA-SF (β = 0.29, p = 0.02) were independent factors affecting HSUV (adjusted R2 = 0.65, p < 0.01). BFI was correlated with HSUV in both older and middle-aged groups.
CONCLUSION: Comprehensive supports, to improve lower extremity function, fatigue, and nutritional status, are required to augment QoL and HSUV in patients with hematological malignancies.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Fatigue; Health state utility values; Hematological malignancy; Nutrition; Physical function; Quality of life

Mesh:

Year:  2022        PMID: 35278136     DOI: 10.1007/s00520-022-06958-y

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  35 in total

1.  Utility values in National Institute for Health and Clinical Excellence (NICE) Technology Appraisals.

Authors:  Jonathan C Tosh; Louise J Longworth; Elisabeth George
Journal:  Value Health       Date:  2011-01       Impact factor: 5.725

2.  Quality of life in cancer patients and its related factors.

Authors:  Farahnaz Abdollahzadeh; Shima Sadat Aghahossini; Azad Rahmani; Iraj Asvadi Kermani
Journal:  J Caring Sci       Date:  2012-05-27

3.  Factors affecting quality of life in cancer patients undergoing chemotherapy.

Authors:  M S Heydarnejad; Dehkordi A Hassanpour; Dehkordi K Solati
Journal:  Afr Health Sci       Date:  2011-06       Impact factor: 0.927

4.  Frailty and health-related quality of life in older women with breast cancer.

Authors:  Grant R Williams; Allison M Deal; Hanna K Sanoff; Kirsten A Nyrop; Emily J Guerard; Mackenzi Pergolotti; Shlomit S Shachar; Bryce B Reeve; Jeannette T Bensen; Seul Ki Choi; Hyman B Muss
Journal:  Support Care Cancer       Date:  2018-11-27       Impact factor: 3.603

5.  EQ-5D Health Utility Scores: Data from a Comprehensive Canadian Cancer Centre.

Authors:  Hiten Naik; Doris Howell; Susie Su; Xin Qiu; M Catherine Brown; Ashlee Vennettilli; Margaret Irwin; Vivien Pat; Hannah Solomon; Tian Wang; Henrique Hon; Lawson Eng; Mary Mahler; Henry Thai; Valerie Ho; Wei Xu; Soo Jin Seung; Nicole Mittmann; Geoffrey Liu
Journal:  Patient       Date:  2017-02       Impact factor: 3.883

6.  Psychosocial QOL is an independent predictor of overall survival in newly diagnosed patients with multiple myeloma.

Authors:  Kathrin Strasser-Weippl; Heinz Ludwig
Journal:  Eur J Haematol       Date:  2008-07-11       Impact factor: 2.997

7.  Patients' experience of chronic lymphocytic leukaemia: baseline health-related quality of life results from the LRF CLL4 trial.

Authors:  Monica Else; Alastair G Smith; Kim Cocks; Sue M Richards; Shirley Crofts; Rachel Wade; Daniel Catovsky
Journal:  Br J Haematol       Date:  2008-10-18       Impact factor: 6.998

8.  Quality of Life in Elderly Cancer Patients Undergoing Chemotherapy.

Authors:  Maria Lavdaniti; Sofia Zyga; Eugenia Vlachou; Despina Sapountzi-Krepia
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

9.  Cancer Related Fatigue and Quality of Life in Patients with Advanced Prostate Cancer Undergoing Chemotherapy.

Authors:  Andreas Charalambous; Christiana Kouta
Journal:  Biomed Res Int       Date:  2016-02-14       Impact factor: 3.411

10.  Influence of Hemoglobin Level on Muscle and Physical Functions, Activities of Daily Living, and Quality of Life in Patients With Hematological Malignancies.

Authors:  Takuya Fukushima; Jiro Nakano; Shun Ishii; Ayumi Natsuzako; Haruna Kawachi; Junya Sakamoto; Yasushi Miyazaki; Minoru Okita
Journal:  Integr Cancer Ther       Date:  2019 Jan-Dec       Impact factor: 3.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.